33,075 followers
New Research: A Novel Model Based on Serum Biomarkers to Predict Primary Non-Response to Infliximab in Crohn’s Disease: Background Infliximab is effective in inducing and maintaining remission in patients with Crohn’s disease (CD), but… https://t.co/dvr5pe